| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,155 |
4,359 |
$244K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,504 |
1,324 |
$110K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
292 |
279 |
$12K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
385 |
355 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
393 |
360 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
678 |
597 |
$1K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
60 |
56 |
$998.95 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
31 |
31 |
$869.10 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
15 |
12 |
$630.00 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
13 |
13 |
$630.00 |
| 81002 |
|
212 |
199 |
$557.61 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
67 |
54 |
$398.75 |
| 90688 |
|
38 |
36 |
$292.00 |
| 3074F |
|
272 |
242 |
$0.00 |
| 3080F |
|
18 |
15 |
$0.00 |
| 3079F |
|
15 |
14 |
$0.00 |
| 3078F |
|
186 |
166 |
$0.00 |